Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1998 Jun;77(11):1792–1798. doi: 10.1038/bjc.1998.298

Epidermal growth factor receptor expression in primary cultured human colorectal carcinoma cells.

W M Tong 1, A Ellinger 1, Y Sheinin 1, H S Cross 1
PMCID: PMC2150335  PMID: 9667648

Abstract

In situ hybridization on human colon tissue demonstrates that epidermal growth factor receptor (EGFR) mRNA expression is strongly increased during tumour progression. To obtain test systems to evaluate the relevance of growth factor action during carcinogenesis, primary cultures from human colorectal carcinomas were established. EGFR distribution was determined in 2 of the 27 primary cultures and was compared with that in well-defined subclones derived from the Caco-2 cell line, which has the unique property to differentiate spontaneously in vitro in a manner similar to normal enterocytes. The primary carcinoma-derived cells had up to three-fold higher total EGFR levels than the Caco-2 subclones and a basal mitotic rate at least fourfold higher. The EGFR affinity constant is 0.26 nmol l(-1), which is similar to that reported in Caco-2 cells. The proliferation rate of Caco-2 cells is mainly induced by EGF from the basolateral cell surface where the majority of receptors are located, whereas primary cultures are strongly stimulated from the apical side also. This corresponds to a three- to fivefold higher level of EGFR at the apical cell surface. This redistribution of EGFR to apical plasma membranes in advanced colon carcinoma cells suggests that autocrine growth factors in the colon lumen may play a significant role during tumour progression.

Full text

PDF
1792

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaulieu J. F., Quaroni A. Clonal analysis of sucrase-isomaltase expression in the human colon adenocarcinoma Caco-2 cells. Biochem J. 1991 Dec 15;280(Pt 3):599–608. doi: 10.1042/bj2800599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Di Marco E., Pierce J. H., Fleming T. P., Kraus M. H., Molloy C. J., Aaronson S. A., Di Fiore P. P. Autocrine interaction between TGF alpha and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. Oncogene. 1989 Jul;4(7):831–838. [PubMed] [Google Scholar]
  3. Gross M. E., Zorbas M. A., Danels Y. J., Garcia R., Gallick G. E., Olive M., Brattain M. G., Boman B. M., Yeoman L. C. Cellular growth response to epidermal growth factor in colon carcinoma cells with an amplified epidermal growth factor receptor derived from a familial adenomatous polyposis patient. Cancer Res. 1991 Mar 1;51(5):1452–1459. [PubMed] [Google Scholar]
  4. Hidalgo I. J., Kato A., Borchardt R. T. Binding of epidermal growth factor by human colon carcinoma cell (Caco-2) monolayers. Biochem Biophys Res Commun. 1989 Apr 14;160(1):317–324. doi: 10.1016/0006-291x(89)91658-6. [DOI] [PubMed] [Google Scholar]
  5. Itakura Y., Sasano H., Shiga C., Furukawa Y., Shiga K., Mori S., Nagura H. Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification. Cancer. 1994 Aug 1;74(3):795–804. doi: 10.1002/1097-0142(19940801)74:3<795::aid-cncr2820740303>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  6. Khalifa M. A., Abdoh A. A., Mannel R. S., Haraway S. D., Walker J. L., Min K. W. Prognostic utility of epidermal growth factor receptor overexpression in endometrial adenocarcinoma. Cancer. 1994 Jan 15;73(2):370–376. doi: 10.1002/1097-0142(19940115)73:2<370::aid-cncr2820730222>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  7. Khazaie K., Schirrmacher V., Lichtner R. B. EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev. 1993 Sep;12(3-4):255–274. doi: 10.1007/BF00665957. [DOI] [PubMed] [Google Scholar]
  8. Malden L. T., Novak U., Burgess A. W. Expression of transforming growth factor alpha messenger RNA in the normal and neoplastic gastro-intestinal tract. Int J Cancer. 1989 Mar 15;43(3):380–384. doi: 10.1002/ijc.2910430305. [DOI] [PubMed] [Google Scholar]
  9. Miller D. L., el-Ashry D., Cheville A. L., Liu Y., McLeskey S. W., Kern F. G. Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: evidence for a role of EGFR in breast cancer growth and progression. Cell Growth Differ. 1994 Dec;5(12):1263–1274. [PubMed] [Google Scholar]
  10. Ménard D., Arsenault P., Pothier P. Biologic effects of epidermal growth factor in human fetal jejunum. Gastroenterology. 1988 Mar;94(3):656–663. doi: 10.1016/0016-5085(88)90236-3. [DOI] [PubMed] [Google Scholar]
  11. Paraskeva C., Finerty S., Mountford R. A., Powell S. C. Specific cytogenetic abnormalities in two new human colorectal adenoma-derived epithelial cell lines. Cancer Res. 1989 Mar 1;49(5):1282–1286. [PubMed] [Google Scholar]
  12. Radinsky R., Bucana C. D., Ellis L. M., Sanchez R., Cleary K. R., Brigati D. J., Fidler I. J. A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas. Cancer Res. 1993 Mar 1;53(5):937–943. [PubMed] [Google Scholar]
  13. Radinsky R., Risin S., Fan D., Dong Z., Bielenberg D., Bucana C. D., Fidler I. J. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res. 1995 Jan;1(1):19–31. [PubMed] [Google Scholar]
  14. Rusch V., Baselga J., Cordon-Cardo C., Orazem J., Zaman M., Hoda S., McIntosh J., Kurie J., Dmitrovsky E. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res. 1993 May 15;53(10 Suppl):2379–2385. [PubMed] [Google Scholar]
  15. Stanton P., Richards S., Reeves J., Nikolic M., Edington K., Clark L., Robertson G., Souter D., Mitchell R., Hendler F. J. Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts. Br J Cancer. 1994 Sep;70(3):427–433. doi: 10.1038/bjc.1994.322. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES